The above article was sent to subscribers in Pharmacy Daily's issue from 12 May 10
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 May 10
STRONG growth in Australia has helped MedAdvisor Solutions achieve robust results for FY24, with a revenue increase of 24.6% on the previous corresponding period to $122.1 million.
AUSTRALIANS with a newly defined type of metastatic breast cancer, HER2-low, will now have access to a life-prolonging drug under the PBS from 01 Sep.
WESFARMERS has today reported strong growth in revenue across its Health division and its Australian Pharmaceutical Industries (API) subsidiary, despite a significant reduction in COVID-19 anti-viral product sales.
FREE Pharmacy Daily subscription - never miss another story!
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.